Pembrolizumab Versus Combined Chemotherapy With Gemcitabine and Paclitaxel: A Comparative Assessment of Clinical Outcomes in Patients With Platinum-refractory Advanced Urothelial Cancer.
In Vivo
; 35(3): 1889-1894, 2021.
Article
in En
| MEDLINE
| ID: mdl-33910878
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Platinum
/
Carcinoma, Transitional Cell
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
In Vivo
Journal subject:
NEOPLASIAS
Year:
2021
Document type:
Article
Affiliation country:
Japan